Ruiwen Shi,Patrick M. Hughes,James A. Burke,Michael R. Robinson,Hui Liu
申请号：
US15159418
公开号：
US20160256382A1
申请日:
2016.05.19
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention provides a sustained release implant for intraocular use to treat elevated intraocular pressure, which implant is configured for intracameral or anterior vitreal administration to a patient with elevated intraocular pressure (IOP), said implant comprising a core of an antihypertensive agent surrounded by a polymer, which limits the rate of passage of the antihypertensive agent from the implant into the eye of said patient and said implant provides a linear rate of release of therapeutically effective amounts of said anti-hypertensive agent into the eye for a period of time of between 14 days and 365 days.
